EDGE niet-invasieve tumorradiochirurgie voor longkanker

Deel dit bericht

Kankergerelateerde sterfgevallen in de Verenigde Staten

The American Cancer Society published its 2015 annual cancer statistics report online on January 5, 2015. The cancer death rate in the United States has fallen by 22% from its peak in 1991 to the present, which means that 1.5 million cancer patients have avoided death. The report also predicted the incidence and mortality of cancer in the United States in 2015.

Longkanker, rectal cancer, prostate cancer, and breast cancer are the most common cancer deaths, accounting for almost half of the total cancer mortality, and lung cancer accounts for 27%. For longkanker, the mortality rate of male patients decreased by 36% from 1991 to 2011, and female patients decreased by 11%. Breast cancer mortality has declined by 35% from the peak to date, while prostaatkanker and rectal cancer have decreased by 47%.

EDGE niet-invasieve radiochirurgie voor het verwijderen van tumoren

Dr. Liao of the Henry Ford Hospital of the United States said that because American hospitals have the world’s most advanced technology and the most experts, the United States has been at the forefront of cancer treatment in the world. The introduction and use of the EDGE non-invasive tumor removal system has further improved the level of cancer treatment in the United States. And the five-year survival rate of cancer patients. The American Henry Ford Hospital Cancer Center is an American hospital with a team of 12 oncologists. Multidisciplinary experts work together to develop a personalized treatment plan for a patient to ensure that the treatment plan is comprehensive and effective.

The EDGE tumor non-invasive radiosurgery treatment system is a cancer treatment system approved by the US FDA in 2014. It is by far the most effective tumor radiosurgery system. It is difficult to perform routine surgery on tumors such as head tumors, lung cancer, spinal tumors, leverkanker and other solid tumors. It has a treatment effect that is difficult to achieve with conventional surgery and radiotherapy equipment, and is the best choice for cancer patients to remove tumor lesions so far.

Compared with conventional surgery and conventional chemotherapy, the EDGE tumor non-invasive surgical removal system has the following advantages:

1. Non-invasive: without any incision, the patient does not need to undergo huge trauma of surgery;

2. Short treatment time: about 10 minutes each treatment time, does not affect the patient’s quality of life;

3. Less treatment times: 1-5 times, once a day, without hospitalization;

4. High efficiency: Up to 5 tumors can be removed at the same time, and the tumor can be removed up to 5-175px, which is suitable for the removal of lesions in almost all patients with solid tumors;

5. Thoroughly: track and lock the escaped tumor and clear it every 10 milliseconds, completely eliminate the tumor cells;

6. High-intensity precision treatment: high-energy, 0.2-millimeter-level precision eliminates tumor cells, and almost no damage to surrounding important organs and tissues;

7. Convenience: no anesthesia and no hospitalization;

8. There are almost no side effects: the patient has no side effects of routine surgery and radiotherapy.

Comparison of EDGE with gamma knife and wave knife:

  1. Higher treatment intensity: EDGE radiation treatment intensity is more than 6 times that of gamma knife and wave knife, eliminating tumor cells more thoroughly.

  2. The treatment effect is better: 0.2 mm precision, dynamic and real-time tracking of tumor cells, the treatment effect is far better than the gamma knife and the wave knife.

  3. More tumor foci can be removed at a time: EDGE can remove up to 5 tumor foci at a time, and the treatment efficiency is higher, while gamma knife and wave knife can only remove one tumor foci at a time.

  4. Shorter time: EDGE resection of multiple brain metastases only takes about 10 minutes, while other radiation treatments such as gamma knife or wave knife take 1 to 5 hours.

  5. EDGE, almost no side effects of gamma knife and wave knife.

Ontvang onze nieuwsbrief

Ontvang updates en mis nooit meer een blog van Cancerfax

Meer om te verkennen

Op mensen gebaseerde CAR T-celtherapie: doorbraken en uitdagingen
CAR T-celtherapie

Op mensen gebaseerde CAR T-celtherapie: doorbraken en uitdagingen

Op mensen gebaseerde CAR T-celtherapie zorgt voor een revolutie in de behandeling van kanker door de eigen immuuncellen van een patiënt genetisch te modificeren om kankercellen te targeten en te vernietigen. Door gebruik te maken van de kracht van het immuunsysteem van het lichaam, bieden deze therapieën krachtige en gepersonaliseerde behandelingen met het potentieel voor langdurige remissie bij verschillende soorten kanker.

Het cytokine-afgiftesyndroom begrijpen: oorzaken, symptomen en behandeling
CAR T-celtherapie

Het cytokine-afgiftesyndroom begrijpen: oorzaken, symptomen en behandeling

Cytokine Release Syndroom (CRS) is een reactie van het immuunsysteem die vaak wordt veroorzaakt door bepaalde behandelingen zoals immunotherapie of CAR-T-celtherapie. Het gaat om een ​​overmatige afgifte van cytokines, waardoor symptomen ontstaan ​​die variëren van koorts en vermoeidheid tot mogelijk levensbedreigende complicaties zoals orgaanschade. Management vereist zorgvuldige monitoring en interventiestrategieën.

Hulp nodig? Ons team staat voor je klaar.

We wensen een spoedig herstel van uw dierbare en nabije.

Begin chat
Wij zijn online! Chat met ons!
Scan de code
Hallo,

Welkom bij KankerFax!

CancerFax is een baanbrekend platform dat zich richt op het verbinden van personen die met kanker in een vergevorderd stadium worden geconfronteerd, met baanbrekende celtherapieën zoals CAR T-celtherapie, TIL-therapie en klinische onderzoeken over de hele wereld.

Laat ons weten wat wij voor u kunnen doen.

1) Kankerbehandeling in het buitenland?
2) CAR T-celtherapie
3) Kankervaccin
4) Online videoconsult
5) Protontherapie